Brii Biosciences Announces Positive Data from the Phase 3 ACTIV-2 Trial

[EarlG]

This is new — a friend of mine just sent it to me. Looks promising…

The monoclonal antibody combination therapy reduced the combined endpoint of hospitalizations and death by 78% over placebo in 837 COVID-19 patients at high risk of clinical progression.

These data demonstrate that high-risk outpatients may benefit from combination BRII-196/BRII-198 therapy up to 10 days following symptom onset.

https://www.briibio.com/news-detial.php?id=328#news

[viva la]

1. That success rate might be might be high enough

That they'll call the placebo phase over and go right to prescribing it. You don't really want to give people placebos when you could save their life with a drug combo like this.

If they've established it's safe, they might shift to comparing 2 different doses so everyone in the trial gets the med. I Wasn't a trial like that period the drug was shown to be so effective, they ma'am they stopped the placebo a placebo phase and went right to dose comparison. I was in a trial like that. The drug was shown to be so effective, they stopped the placebo phase and went right to dose comparison.